187 related articles for article (PubMed ID: 26279691)
1. Imaging Findings and Literature Review of (18)F-FDG PET/CT in Primary Systemic AL Amyloidosis.
Lee JH; Lee GY; Kim SJ; Kim KH; Jeon ES; Lee KH; Kim BT; Choi JY
Nucl Med Mol Imaging; 2015 Sep; 49(3):182-90. PubMed ID: 26279691
[TBL] [Abstract][Full Text] [Related]
2. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
3. Early Detection of Multiorgan Light-Chain Amyloidosis by Whole-Body
Ehman EC; El-Sady MS; Kijewski MF; Khor YM; Jacob S; Ruberg FL; Sanchorawala V; Landau H; Yee AJ; Bianchi G; Di Carli MF; Falk RH; Hyun H; Dorbala S
J Nucl Med; 2019 Sep; 60(9):1234-1239. PubMed ID: 30954943
[TBL] [Abstract][Full Text] [Related]
4. Quantitative [
Khor YM; Cuddy S; Harms HJ; Kijewski MF; Park MA; Robertson M; Hyun H; Di Carli MF; Bianchi G; Landau H; Yee A; Sanchorawala V; Ruberg FL; Liao R; Berk J; Falk RH; Dorbala S
Eur J Nucl Med Mol Imaging; 2020 Jul; 47(8):1998-2009. PubMed ID: 31807884
[TBL] [Abstract][Full Text] [Related]
5. Value of (18)F-FDG PET/CT in the Detection of Ovarian Malignancy.
Park T; Lee S; Park S; Lee E; Pahk K; Rhee S; Cho J; Kim C; Eo JS; Choe JG; Kim S
Nucl Med Mol Imaging; 2015 Mar; 49(1):42-51. PubMed ID: 25774237
[TBL] [Abstract][Full Text] [Related]
6. MIB-1 Index-Stratified Assessment of Dual-Tracer PET/CT with
Sampathirao N; Basu S
J Nucl Med Technol; 2017 Mar; 45(1):34-41. PubMed ID: 28154019
[TBL] [Abstract][Full Text] [Related]
7. Usefulness and pitfalls of F-18-FDG PET/CT for diagnosing extramedullary acute leukemia.
Zhou WL; Wu HB; Wang LJ; Tian Y; Dong Y; Wang QS
Eur J Radiol; 2016 Jan; 85(1):205-210. PubMed ID: 26724667
[TBL] [Abstract][Full Text] [Related]
8. 18F-FDG PET/CT in patients with amyloid light-chain amyloidosis: case-series and literature review.
Mekinian A; Jaccard A; Soussan M; Launay D; Berthier S; Federici L; Lefèvre G; Valeyre D; Dhote R; Fain O;
Amyloid; 2012 Jun; 19(2):94-8. PubMed ID: 22587492
[TBL] [Abstract][Full Text] [Related]
9. 18F-FLT PET/CT imaging is not competent for the pretreatment evaluation of metastatic gastric cancer: a comparison with 18F-FDG PET/CT imaging.
Zhou M; Wang C; Hu S; Zhang Y; Yao Z; Li J; Guo W; Zhang Y
Nucl Med Commun; 2013 Jul; 34(7):694-700. PubMed ID: 23604223
[TBL] [Abstract][Full Text] [Related]
10. 18F-FDG PET scanning in pulmonary amyloidosis.
Baqir M; Lowe V; Yi ES; Ryu JH
J Nucl Med; 2014 Apr; 55(4):565-8. PubMed ID: 24556593
[TBL] [Abstract][Full Text] [Related]
11. [Localized Amyloidosis Involving the Nasal Cavity].
Koukalová R; Szturz P; Svobodová I; Stulík J; Řehák Z
Klin Onkol; 2016; 29(3):216-9. PubMed ID: 27296407
[TBL] [Abstract][Full Text] [Related]
12. 18F-Florbetapir and 18F-FDG PET/CT in Systemic Immunoglobulin Light Chain Amyloidosis Involving the Peripheral Nerves.
Broski SM; Spinner RJ; Howe BM; Dispenzieri A; Johnson GB
Clin Nucl Med; 2016 Feb; 41(2):e115-7. PubMed ID: 26284768
[TBL] [Abstract][Full Text] [Related]
13. Clinical Utility of 18F-Florbetaben PET for Detecting Amyloidosis Associated With Multiple Myeloma: A Prospective Case-Control Study.
Seo M; Cha HJ; Kim M; Park SH; Lim JH; Choi Y; Lee YJ; Park SH; Jo JC
Clin Nucl Med; 2019 Sep; 44(9):e503-e509. PubMed ID: 31283608
[TBL] [Abstract][Full Text] [Related]
14. [Clinical value of (18)F-FDGPET/CT in differentiation between benign lesions and lung cancer for large shadows in patients with pneumoconiosis].
Wang Y; Zhang H; Cui X; Fang N; Zeng L; Zhang C
Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2014 Mar; 32(3):186-9. PubMed ID: 24641846
[TBL] [Abstract][Full Text] [Related]
15. Role of
Dolci C; Ceppi L; Guerra L; Crivellaro C; Lamanna M; Adorni M; Elisei F; Bonazzi CM; Sina F; Fruscio R; Messa C
Int J Gynecol Cancer; 2019 Oct; 29(8):1298-1303. PubMed ID: 31366569
[TBL] [Abstract][Full Text] [Related]
16. Should 18F-FDG PET/CT Be Routinely Performed in the Clinical Staging of Locally Advanced Gastric Adenocarcinoma?
Perlaza P; Ortín J; Pagès M; Buxó E; Fernández-Esparrach G; Colletti PM; Rubello D; Mayoral M; Sánchez N; Ruiz C; Ginés A; Fuster D
Clin Nucl Med; 2018 Jun; 43(6):402-410. PubMed ID: 29485442
[TBL] [Abstract][Full Text] [Related]
17. Areas of high 18F-FDG uptake on preradiotherapy PET/CT identify preferential sites of local relapse after chemoradiotherapy for non-small cell lung cancer.
Calais J; Thureau S; Dubray B; Modzelewski R; Thiberville L; Gardin I; Vera P
J Nucl Med; 2015 Feb; 56(2):196-203. PubMed ID: 25572091
[TBL] [Abstract][Full Text] [Related]
18. Does 18F-FDG PET/MRI reduce the number of indeterminate abdominal incidentalomas compared with 18F-FDG PET/CT?
Schaarschmidt BM; Grueneisen J; Heusch P; Gomez B; Umutlu L; Ruhlmann V; Rosenbaum-Krumme S; Antoch G; Buchbender C
Nucl Med Commun; 2015 Jun; 36(6):588-95. PubMed ID: 25759944
[TBL] [Abstract][Full Text] [Related]
19.
Wang Z; Ma D; Yang J
Hell J Nucl Med; 2016; 19(3):241-244. PubMed ID: 27824963
[TBL] [Abstract][Full Text] [Related]
20. A first described chest wall metastasis from colon cancer demonstrated with (18)F-FDG PET/CT.
Jiang L; Gao Y; Sheng S; Xu M; Lu L; Lu H
Hell J Nucl Med; 2011; 14(3):316-7. PubMed ID: 22087459
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
